Finance

Lists
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
4,10 USD
-1,20%
(-0,050) 1D
3,84 USD
-6,34% (-0,26)
Pre-market
Closed: 14-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
4,11 USD
High
4,29 USD
Low
3,91 USD
Mkt. cap
19,70 млн
Avg. vol.
82,54 миң
Volume
4,41 миң
52-wk high
23,50 USD
52-wk low
3,25 USD
EPS
-423,73 USD
Beta
1,56
Shares outstanding
4,80 млн
No. of employees
5
Open
4,11 USD
High
4,29 USD
Low
3,91 USD
Mkt. cap
19,70 млн
Avg. vol.
82,54 миң
Volume
4,41 миң
52-wk high
23,50 USD
52-wk low
3,25 USD
EPS
-423,73 USD
Beta
1,56
Shares outstanding
4,80 млн
No. of employees
5
News stories
From web sources and news partners
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
Sector-
Websitequoinpharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current 4,10 USD
35,00 USD (+753,66%)
Average
22,25 USD (+442,68%)
Lowest
14,00 USD (+241,46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Initiated
14,00 USD
+241,5%
10/12/2026
Thomas Flaten
Lake Street
Buy
Initiated
20,00 USD
+387,8%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
20,00 USD
+387,8%
09/03/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
35,00 USD
+753,7%
08/17/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
12,00 USD
+192,7%
06/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
30,00 USD
+631,7%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,28 млн
3,10 млн
3,43 млн
3,63 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 млн
1,42 млн
1,70 млн
1,85 млн
Operating expense
4,02 млн
4,52 млн
5,13 млн
5,47 млн
Total operating expenses
4,02 млн
4,52 млн
5,13 млн
5,47 млн
Operating income
-4,02 млн
-4,52 млн
-5,13 млн
-5,47 млн
Other non operating income
9,49 миң
364,00
-13,30 миң
1,58 миң
EBT including unusual items
-3,95 млн
-4,35 млн
-5,00 млн
-5,37 млн
EBT excluding unusual items
-3,95 млн
-4,35 млн
-5,00 млн
-5,37 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,95 млн
-4,35 млн
-5,00 млн
-5,37 млн
Net profit margin
-
-
-
-
Earnings per share
-6,70
-
-1,77
-1,90
Interest and investment income
62,27 миң
171,70 миң
146,78 миң
100,95 миң
Interest expense
-
-
-
-
Net interest expenses
62,27 миң
171,70 миң
146,78 миң
100,95 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,99 млн
-4,50 млн
-5,11 млн
-5,45 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору